We aim to deliver meaningful experiences through great design, awesome development and remarkable content.
UPTEC Asprela I
BEAT Therapeutics is a pharmaceutical company driven by an unwavering commitment to transforming cancer care.
Our mission is clear: to develop more effective therapeutic options for patients facing hard-to-treat cancers.We unleash the potential of nature’s most powerful compounds, to deliver a therapeutic against cancers with high resistance to conventional treatments and low survival rates.Our first drug candidate is a first-in-class therapy effective against BRCA1/BARD1 interaction, a highly validated target in cancer.
The uniqueness of this therapy lies in its exceptional efficacy and a precision mechanism that ensures safety, while successfully preventing resistance and effectively eliminating chemotherapy-resistant cells, making it a true breakthrough in cancer treatment.
Overall, it has the potential to translate into a therapy that can provide higher clinical benefit for patients with fewer side effects.